Navigation Links
Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant
Date:11/6/2009

olved in the investigation were the VENTAK PRIZM(®) 2, the CONTAK RENEWAL(®) and the CONTAK RENEWAL 2 devices, which were the subjects of the 2005 product advisories.

The table below reconciles the Company's updated third quarter and year-to-date 2009 financial results to those previously reported. The adjustments in the table are also reflected in the Company's Form 10-Q, which will be filed later today. 

                                                    Q3 2009 Results
                                             ------------------------------
                                                       Litigation-
                                            Previously   Related      As
    (in millions, except per share data)     Reported     Charge    Updated
    ------------------------------------     --------     ------    -------
    Income (loss) before income taxes          $250       $(294)      $(44)
    Net income (loss)                          $200       $(294)      $(94)

    GAAP EPS                                  $0.13      $(0.19)    $(0.06)
    Adjusted EPS                              $0.19                  $0.19



                                                   Q3 2009 YTD Results
                                             ------------------------------
                                                       Litigation-
                                            Previously   Related      As
    (in millions, except per share data)     Reported     Charge    Updated
    ------------------------------------     --------     ------    -------
    Income before income taxes                 $333       $(294)       $39
    Net income                                 $345       $(294)       $51

    GAAP EPS                                  $0.23      $(0.20)     $0.03
    Adjusted EPS                              $0.58                  $0.58

In addition, the Company has updated its full-
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FirstCall/--HeskaCorporation(HSKA);("Heska"),alead...ctstotheveterinaryindustry,announcedtodayagreement...dgasproductsandaffiliatedconsumablesfortheveterina...bin/prnh/20000622/HESKALOGO ) ,, "HeskaandRoche...edpoint-of-carediagnostics,"commentedMichaelMcGinl...
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...re/--RegadoBiosciences,aprivatelyheldcompanyleadin...ontrolagents,announcedthatDavidMazzo,PhD,CEOandPre...HealthCareConferenceattheNewYorkPalaceHotelinNewYo...ST)onTuesday,December1andwillincludeanoverviewofth...program,theanticoagulantsystem,REG1.Thehealthcarei...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Walking hazard 3A Cell phone use but not music reduces pedestrian safety 61422 1Walking hazard 3A Cell phone use but not music reduces pedestrian safety 61422 2The evolving manager stereotype 3A Gender a factor in measuring a teams performance 61420 17th International Chronic Total Occlusion Summit in New York City 61418 1
... MELBOURNE, Australia, May 03, 2007 /PRNewswire-Fi...nced today that the Company,intends to initiate a ...y and safety of the improved formulation of its tr...ing long-acting insulin.,The trial is expected to ...nsulin gel is being developed as a novel "needle-f...
...CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 3, 2007 - X...emonstrating that,Symadex(TM) reversed the clinica...animal model for multiple sclerosis. The presentat...r of Diagnostic,Radiology at the University of Wes...rchers from Xanthus in a poster session at the,59t...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3
(Date:11/25/2009)...eumatoid arthritis, could help newly diagnosed dia...25 (HealthDay News) -- A drug commonly used to tre... now also shows some promise in helping patients n..., rituximab (Rituxan), helped patients keep produc...ease had destroyed some of their pancreatic beta c...
(Date:11/25/2009)...ical symptoms, study finds , , WEDNESDA...ffects are among the potential problems faced by l...reated with cisplatin-based chemotherapy, a new st...gian men treated for unilateral testicular cancer ... survey conducted from 1998 to 2002. , The rese...
(Date:11/25/2009)...wire-USNewswire/--TheAmericanAssociationforHomecar....2128,whichisdesignedtosubstantiallyimprovetoolsan...lwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,, T...ssociationforHomecareoutlinedinits13-pointanti-fra...inFebruary.Thoseprovisionsincludecallingforreal-ti...
(Date:11/25/2009)...ancer also can reverse a rare stomach disorder and...isease, researchers at Vanderbilt University Medic...auses thickening of the stomach lining, severe abd...a and swelling in the feet and ankles due to prote...c cancer. Previously, the only effective treatment...
(Date:11/25/2009)...hat mimicked parts of speech colored perception of...y News) -- People can "hear" not only with their e... , In fact, sensations on the skin designed to ...le decipher sounds better, the Canadian scientists...her we could use tactile information in this way,"...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...est assesses osteoporosis risk and helps provide p...r bone health, CINCINNATI and BRIDGEWATER, N.J., ...tand your risk factors for osteoporosis, using a,n...test asks less than 20 simple questions about fami...
...nsecutive Year in Deloitte,s Technology Fast 50 Pr...stems,Inc. (Nasdaq: CASM ), a medical device comp... monitoring, today announced that it has been name...life sciences companies in the area by Deloitte & ...
...nt to Host Conference Call and Webcast Same Aftern...,BZI), a provider of functional foods, beverages a...he Company will report its financial and,operation...ernoon beginning at,4:15 PM Eastern Time, and invi...
...LIS, Oct. 19 Uroplasty, Inc. (Amex:,UPI) announce... with the,U.S. Securities and Exchange Commission ...10,000,000 (exclusive of over-allotment option) of...ic offering.,A copy of the prospectus relating to ...
...xis to Demonstrate Advanced Coronary & Peripheral ...ping at TCT 2007 Stereotaxis, Mobile Vasc...Stereotaxis, Inc. (Nasdaq:,STXS) announced today t...erapeutics (TCT) symposium in Washington,D.C., Oct...
...UGE, La., Oct. 19 Amedisys, Inc.,(Nasdaq: AMED or...lth,nursing companies, today announced that it int...ter ended September 30, 2007 pre-market on Tuesday...onference call, please dial 800-683-1525,(Domestic...
Other Medicine News:Health News:Sixty Seconds That Can Change Your Life 2Health News:Sixty Seconds That Can Change Your Life 3Health News:Sixty Seconds That Can Change Your Life 4Health News:Sixty Seconds That Can Change Your Life 5Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 2Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 3Health News:CAS Medical Systems, Inc. Ranked Among Connecticut's Fastest Growing Technology Companies 4Health News:XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007 2Health News:XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007 3Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 2Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 4Health News:Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results 2
...areCollect™ improves the specimen collection ... patient information on the handheld at the bedsid...pecific patient. Collection status information can...educe redraws, enhancing patient comfort, and maki...
...rizon Admin-Rx is a bar-code medication administra...the medication administration process with bar-cod...canner in a handheld or laptop device to verify th... at the right time in the right dosage via the rig...
wCareMed™
...diMAR™ is the newest Mediware product, which ...record. MediMAR produces a dynamic and complete re...including clinician orders, medication list, aller...ion or alerts that increase patient safety. MediMA...
Medicine Products: